G J Wolbink
Overview
Explore the profile of G J Wolbink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
1813
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Buchem-Post N, Ouwerkerk W, Bekkenk M, Wolkerstorfer A, Spuls P, Musters A, et al.
J Dermatol
. 2025 Feb;
PMID: 39950702
During the COVID-19 pandemic, the daily life of many patients with dermatological immune-mediated inflammatory diseases (DIMIDs), such as atopic dermatitis (AD), psoriasis, and vitiligo, was impacted by social restrictions caused...
2.
Ruwaard J, L Ami M, Kneepkens E, Krieckaert C, Nurmohamed M, Hooijberg F, et al.
Scand J Rheumatol
. 2022 Mar;
52(2):129-136.
PMID: 35234569
Objective: The majority of patients with a rheumatic disease treated with etanercept may be overexposed. Data regarding etanercept tapering are scarce, particularly in psoriatic arthritis (PsA) and ankylosing spondylitis (AS)....
3.
Boekel L, Wolbink G
Lancet Rheumatol
. 2022 Jan;
4(3):e154-e155.
PMID: 34977601
No abstract available.
4.
van Kempen Z, Wieske L, Stalman E, Kummer L, van Dam P, Volkers A, et al.
Mult Scler Relat Disord
. 2021 Nov;
57:103416.
PMID: 34847379
Objective: The objective of this study was to measure humoral responses after SARS-CoV-2 vaccination in MS patients treated with ocrelizumab (OCR) compared to MS patients without disease modifying therapies (DMTs)...
5.
Koers J, Derksen N, Falkenburg W, Ooijevaar-de Heer P, Nurmohamed M, Wolbink G, et al.
Scand J Rheumatol
. 2021 Nov;
52(1):25-32.
PMID: 34726124
Objective: Rheumatoid arthritis (RA) is characterized by systemic inflammation and the presence of anti-citrullinated protein antibodies (ACPAs), which contain remarkably high levels of Fab glycosylation. Anti-hinge antibodies (AHAs) recognize immunoglobulin...
6.
Boekel L, Hooijberg F, Vogelzang E, Klarenbeek P, Bos W, Tas S, et al.
Arthritis Res Ther
. 2021 Aug;
23(1):207.
PMID: 34348783
Clinical research projects often use traditional methods in which data collection and signing informed consent forms rely on patients' visits to the research institutes. However, during challenging times when the...
7.
L Ami M, Ruwaard J, Krieckaert C, Nurmohamed M, van Vollenhoven R, Rispens T, et al.
Scand J Rheumatol
. 2019 Apr;
48(4):266-270.
PMID: 31012365
: Inadequate response to adalimumab can be caused by insufficient blockade of the target tumour necrosis factor (TNF) at low serum concentrations. In such cases, patients may respond to another...
8.
Menting S, van den Reek J, Baerveldt E, de Jong E, Prens E, Lecluse L, et al.
Br J Dermatol
. 2015 Apr;
173(3):855-7.
PMID: 25865153
No abstract available.
9.
van Schie K, Hart M, de Groot E, Kruithof S, Aarden L, Wolbink G, et al.
Ann Rheum Dis
. 2015 Apr;
74(8):e41.
PMID: 25854585
No abstract available.
10.
Vogelzang E, Pouw M, Nurmohamed M, Kneepkens E, Rispens T, Wolbink G, et al.
Ann Rheum Dis
. 2014 Nov;
74(2):474-5.
PMID: 25433018
No abstract available.